Monday, 27 August 2018

Inguinal Hernia Market, Segments, Growth and Value Chain 2018


Market Synopsis of the Global Inguinal Hernia Market
Inguinal hernia results when a part of small intestine bulges out through a weak area in the lower abdominal wall. Two types of inguinal hernia are known- direct and indirect inguinal hernia.  Direct inguinal hernia occurs in males resulting into the weakening of the abdominal muscles around the inguinal canal. Whereas, indirect inguinal hernia is caused by the defects in the abdominal wall present at the birth. The prevalence of inguinal hernia is found to high in males, which is attributed to stress and increasing age. 
The market for inguinal hernia is expected to show a healthy growth owing to increasing cases of hernia repair and increasing adoption of laparoscopic techniques across the globe. Furthermore, increasing number of hernia repair surgeries also contributes to the progress of the market. Therefore, demand for hernia repair devices is found to be increasing. On the other hand, High cost of the hernia repair devices may act as a restrain for the market growth.
The global inguinal hernia market is expected to grow at a CAGR of 10.8% during the forecast period.
Key Players in the Global Inguinal hernia Market
 

Some of the key players in this market are Ethicon, Inc. (U.S.), Medtronic (U.S.), C.R. Bard, Inc. (U.S.), Atrium (U.S.), W.L. Gore & Associates Inc. (U.S.), Acelity (U.S.) and B Braun Melsungen AG (Germany).


Segments    
The global inguinal hernia market is segmented on the basis of type, diagnosis, treatment, and hernia mesh type.
On the basis of types, the market is segmented into direct and indirect hernia.  
On the basis of diagnosis, the market is segmented into physical examination and imaging test. Imaging tests is further segmented into abdominal ultrasound, CT scan, and Magnetic Resonance Imaging (MRI).
On the basis of treatment, the market is segmented into open hernia repair, laparoscopy, and others.
On the basis of hernia mesh type, the market is segmented into synthetic mesh, and biologic mesh.
Regional Analysis of the Global Inguinal Hernia Market              
America is the largest market for inguinal hernia owing to rising prevalence of inguinal hernia in the U.S. and increasing number of surgical procedures such as groin hernia repair. According to the article published in PLOS, in the U.S., groin hernia repair is commonly performed in both adults and children with inguinal hernias constituting more than 95% of all groin hernia repairs.
Europe is the second largest market owing an increase in the prevalence of inguinal hernia and extensive demand for hernia repair devices. The U.K is expected to be the largest market in Europe.  According to the New England Journal of Medicine, more than 90,000 surgical intervention for inguinal hernia were performed in Europe.
In Asia Pacific, the demand for laparoscopic procedures for inguinal hernia is increasing and China is expected to be the largest market in Asia Pacific followed by Japan and India. According to the Asia Pacific hernia society, extrapolated incidence of hernia in India is 1,957,850.
The Middle East & Africa also shows a steady rise in the market owing to extensive use of hernia mesh devices for surgeries in the Middle East. In the Middle East, Iran is expected to be the largest market followed by Saudi Arabia. In Africa, high cost of hernia repair restrained the market growth. In the past, laparoscopy was rarely performed for hernia repair in Africa.

Detailed Table of Contents:
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants

...Continued

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Anesthesia Machine Market Demonstrate Vigorous Growth by Size, Share, Revenue and Forecasts by 2023


Market Scenario:
The anesthetic machine is used to deliver and support anesthesia under the direct supervision of anaesthesiologists. The global anesthetic machine market was valued at 9.4 billion in 2016 and which is expected to reach 14.75 billion at a CAGR of 7.8 during the forecast period of 2016 to 2023.
These figures swell when we include other specialties such as trauma and gynecology, which are capturing a broader market. Advancements in anesthesia system technology and the shift away from general anesthesia towards partial anesthesia, coupled with the development of short-acting anesthetics is driving a change in trend. Thus, the predominant continuous flow anesthetic machine or Boyles anesthesia machine is giving way to the intermittent flow anesthetic machine. Another trend catching on is the growing use of computer controlled anesthesia and patient monitoring devices.
Portability and miniaturization have led to growing adoption of anesthesia in point of care surgeries. The growing capabilities of anesthetic devices such as the ability to deliver variable flow, minimum low flow rate, scavenging systems to capture waste gases, emergency systems such as oxygen flush systems and others are driving the market.
The market restraints of the anaesthetic market are the high cost of installation and maintenance, scarcity of anesthesiologists, the risk of infection, complications such as pain, and deaths due to overdose and others. The mortality rate for general anesthesia is 1:10,000 as cited by many studies. Thus, advancements in devices due to safety concerns is strongly correlated with market growth.
Regional analysis
North America commands the most significant share of the market due to a large number of surgeries and sizeable public expenditure on healthcare. The U.S. spends a substantial proportion of the GDP on healthcare, of which approximately 16 % in 2016. However, the recent reimbursement cuts by the government of U.S. may hinder the market.
Europe market is dominated by Germany, France, and the U.K. Owing to the extensive medical device industry of Germany. Poland, Spain, and Italy also have a sizable market share of the European market.
Asia Pacific region is expected to demonstrate the fastest growth for the anesthesia machine market is owing to economic development and developing healthcare infrastructure. China is expected to drive a considerable growth followed by India. The leading domestic players, in China, are Tuoren Medical, Shengguang Medical, and Qiangjian Medical, which account for approximately 16 % of the local market share of China.
The Middle East and Africa are led by Gulf economies of Saudi Arabia, UAE, Kuwait, and Qatar. The Middle East is a market to watch owing to its high wealth and the development of large hospital complexes in the region such as the King Fahd hospital, Riyadh. The market is however dependent on petrodollar and the expat population, which is a threat to its stability. The kingdom of Saudi Arabia reduced its healthcare spending by 35 percent in the year 2016 to wean the downfall of revenues owing to falling crude oil prices. Saudi Arabia and other Gulf nations spend approximately 75 % of total healthcare expenditure through public budgets which must be seen as a threat as well as opportunity for the private players to capture the domestic market of Gulf economies.
Thus, the short-term prospects for the Middle East region are expected to rise to previous levels after 2018. The government is undertaking harsh fiscal adjustment owing to weak oil price. However, the high and satisfactory foreign reserves of Saudi Arabia, which equal over 95 % of GDP, and low public debt stock of just 5.8 % of GDP in 2015 are enough to say that the cuts will not be too drastic!
The Latin America market is characterized by poor domestic capacity and capability of production. China is expected to increase its share of the medical devices imports of Brazil, especially in low-end devices. Among the regions of Brazil, São Paulo, Minas Gerais, Bahia, Rio de Janeiro and Parana tops the healthcare expenditure list. However, the differential regional healthcare availability owing to extreme social and economic differentiation of the Brazilian population is the prime threat to the market. The inadequate health care in its vast rural areas, political turmoil, the weak Brazilian Real are the other threats to the market.
Competitive Landscape
Heyer Medical AG, Fisher & Paykel Healthcare, Koninklijke Philips N.V, Draeger, GE Healthcare, Covidien, Smiths Medical, Mindray DS USA Inc., and Teleflex Inc.


About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Smoking Cessation And Nicotine De-Addiction Market Segments, Opportunity, Growth and Forecast by End-use Industry, Key Competitors and Market value 2018

Market Scenario
Smoking cessation and nicotine de-addiction are drugs and therapies used in the treatment of withdrawal symptoms associated with the cessation of nicotine. According to the World Health Organization tobacco kills around 6 million people each year and of these almost 5 million deaths are the result of direct tobacco use and approximately 600,000 are the result of passive smoking. Tobacco also derives its users of income, raises healthcare cost and hinder economic development.
Nicotine use also is a risk factor for many diseases and disorders such as cardiovascular diseases, cancer etc. Green tobacco sickness, caused by nicotine absorption through the skin by the handling of wet tobacco leaves in tobacco industry is also a concern especially among children. Tobacco quitting assistance in the form of national cessation services with cost-coverage are available in only 24 countries, representing 15% of the world's population. Only 42 countries, representing 19% of the world's population, have instituted advertisement regulations such as pictorial warnings.
The other market driving factors include increasing desire and drives to quit smoking and active role of social and health organizations against tobacco use, the prohibitive costs due to high taxes leveraged on tobacco products, social stigma imposed on tobacco users etc. The other critical market driving factor is the huge number of unmet needs. The World Health Organization (WHO), estimates around 1,100 million smokers worldwide with emerging economies accounting for around 70% of the global smoker population.
The market trends include development of better products such as nicotine gums and patches, e-cigarette’s etc.
The market for Middle East and Africa smoking cessation and nicotine de-addiction was estimated to be around $ 1040 million in 2016. Taking all factors into consideration, we expect the Middle East and Africa smoking cessation and nicotine de-addiction market to reach around $ 2108.38 million, by 2022 growing at a CAGR of 12.5%.
Key Players of Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market
Some of the key players in this market are Pfizer Inc, VMR Products LLC, Johnson & Johnson, Novartis International AG, Cipla Inc., and GlaxoSmithKline plc. Nicotek LLC., and Lorillard, Inc. and others.

Segments:
Middle East and Africa smoking cessation and nicotine de-addiction products market has been segmented on the basis of treatment which comprises of pharmacological, therapies etc. On the basis of product type; market is segmented into drugs, inhalers, patches, sprays and gums and others. On the basis of distribution channels; market is segmented into pharmacies, online and de-addiction centers.

Regional Analysis of Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market
UAE is the largest market in the entire Middle East and Africa smoking cessation and nicotine de-addiction products market closely followed by Egypt. Algeria and South Africa followed by Ethiopia are fastest growing markets in Africa. The rest of Africa market however has maximum population with unmet medical needs.

Apply for Exclusive Discount @
https://www.marketresearchfuture.com/check-discount/2737
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry


About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Biological Computers Market to witness a significant Growth in terms of value during forecast period 2018-2023

Market Synopsis of the Global Biological computers Market
Biological computers, also known as DNA computers, are microcomputers designed for their use in the field of medicine. This implantable device can be used for various functions such as monitoring the activities of the body or inducing therapeutic effects. Hardware, software, input, and output are the four major components of a biological computer. These components are made of DNA, RNA and proteins. Biological computers are able to perform mathematical calculations that enable the researcher to construct a system of biosensors. This system of biosensors can detect or target specific types of cells such as cancer cells in the patient’s body.
Rising prevalence of cancer, and increasing demand for DNA or gene chips are some of the major factors driving the growth of this market across the globe. Furthermore, increasing healthcare expenditure and overall growth of the healthcare industry also influence the market growth. Splendid research in the field of oncology also boosts the market.

As per the report of the Centers for Disease Control and Prevention (CDC), in 2014, over 14.1 million of new cancer cases were registered worldwide.
The global biological computers market is expected to grow at a CAGR of 7.1% during the forecast period 2017-2023.
Segments                                                                                                                                            
The global biological computers market is segmented on the basis of component, application, and end user.
On the basis of the component, market is segmented into hardware, software, input, and output.
On the basis of the application, the market is segmented into oncology, molecular genetics, nanobiotechnology, and others.
On the basis of the end user, the market is segmented into pharmaceutical & biotechnology companies, research centers, healthcare it companies, hospital & clinics, and others.
Regional Analysis of the Global Biological Computers Market            
The Americas hold the first position in the biological computers market owing to the rising prevalence of cancer in the U.S., and increasing demand for new cancer diagnostic and treatment services. In the Americas, North America is the largest market owing to the presence of key players in the healthcare IT industry.
Europe is the second largest market for biological computers. In Europe, there is an increasing demand for healthcare IT solutions and extensive research and development activities is taking place by clinical research and academic institutes for cancer treatment. According to Cancer Research UK, in 2014, 356,860 new cases of cancer were reported, including 579 cases of bone cancer.  
The market in Asia Pacific is expected to grow at the fastest pace and is driven by the high prevalence of chronic disease such as cancer, obesity, diabetes and other. India, China, and Japan are major contributors to the growth of the market. This growth is attributed to an increasing demand for technologically advanced medical devices and accessories such as gene chips for research activities. Availability of highly qualified medical professionals dedicated to research in biological systems is also a contributing factor. The various other factors affecting the growth of the market in Asia Pacific are rising geriatric population, demand for advanced therapies, government initiatives, and increasing public awareness about various diseases and the available treatments.
Additionally, healthcare spending in Asia Pacific expanded in 2016 due to an extension of state healthcare programs, and the increasing affluence of the population. Organization for Economic Co-operation and Development (ECOD) stated that growth in India will remain high at 7.3% in 2017.
The Middle East & Africa also show a steady rise in the market owing to low technological penetration and increasing awareness about cancer treatment. In the Middle East & Africa, Middle East captures the largest market share for biological medicines owing to the availability of better healthcare infrastructure and wide scope for research.
Key Players in the Global Biological computers Market          
Some of the key players in this market are Microsoft (U.S.), IBM (U.S.), Thermofisher Scientific (U.S.), Illumina, Inc. (U.S.), IndieBio (U.S.), Emulate Inc. (U.S.), and others. Key players manufactruing DNA or gene chips are Sequenom Inc., Merck KGaA (U.S.), Macrogen Corp (Republic of Korea), Bioneer Corporation (Republic of Korea), Biometrix Technology Inc (U.S.), Wafergen Biosystems Inc. (U.S.), and Eurofins Genomics India Pvt Ltd. (India).
Apply for Exclusive Discount @

Detailed Table of Contents:
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
...Continued

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Wednesday, 22 August 2018

Antipsychotic Drugs Market Segments, Opportunity, Growth and Forecast by End-use Industry, Key Competitors and Market value 2018

Market Scenario: 
Psychosis are a group of disorders with serious distortion of thought, behavior, recognition of reality and perception. The patient may have delusions and hallucinations and may have misperception and wrong evaluation of situation, facts or other people.
The most critical market driving factor for anti-psychotic drugs is the rising cases of psychosis and mental disorders. Following are some estimates about psychosis according to the World Health Organization (WHO):
Depression affects an estimated 300 million people in the world.
Bipolar affective disorder takes a toll on about 60 million people worldwide.
Schizophrenia, a severe mental disorder, affects about 21 million people worldwide.
Dementia has a prevalence in about 47.5 million people worldwide
One fourth of people are affected by mental or neurological disorders at some point in their lives.
The current number of untapped patients are of an order of around 450 million currently suffering from such conditions. 


The treatment scenario is no different and the least it is said the better. According to WHO, the gap between the unmet needs in low- and middle-income countries is between 76% and 85% of people with mental disorders. Even in high-income countries the unmet medical needs gap is of an order of 35% and 50% of people with mental disorders. Thus there exists a huge market with unmet medical needs which needs to be tapped. Other very important market driving factor is increasing focus of governments and health care organizations on mental health. For example, WHO's initiated its Mental Health Gap Action Programme in 2008, to expand the coverage of mental health treatment and service across the world.
However there are huge formidable barriers which remain a challenge to expand the market and the anti-psychotic drugs market has shown growth par below their potential market due to a host of factors. The critical market restraint is the poor efficiency and efficacy of anti-psychotic drugs. The side effects of these drugs is another depressing story to tell, which ranges from insomnia, drowsiness, vomiting to the high addiction rate. Social stigma also constraints the market with an estimated two-thirds of patients never seeking help. The poor drug development pipeline is a future market threat. The drug pipeline for anti-psychotics is devoid of any novel acting drug candidate. Strict regulatory framework is another deterrent for companies developing anti-psychotics.
The global market for antipsychotic drugs is expected to reach around USD 18.5 billion by the end of the forecast period and is expected to grow at a CAGR of ~4.3%.
Key Players for Global Antipsychotic Drugs Market:
Some of the key players in this market are: Eli Lilly & Co., Bristol-Myers Squibb, AstraZeneca, Pfizer inc., GlaxoSmithKline plc., Johnson & Johnson  and others.
Segments:
Global antipsychotic drugs market has been segmented on the basis of therapeutic applications, which comprises schizophrenia, bipolar disorder, depression, dementia and others. On the basis of generations; market is segmented into first, second and third.
Regional Analysis of Global Antipsychotic Drugs Market:
Globally America is the largest market for antipsychotic Drugs. The American market for antipsychotic drugs represents about 47 % of world market in 2016. Rapid uptake of new drug molecules and excellent reimbursements scenario in the U.S. are the two most important factors for the dominance of America. Europe is the second-largest market for antipsychotic drugs. Asia pacific region is expected to be fastest growing region in antipsychotic drugs market.

Detailed Table of Contents:
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
...Continued

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com